Morgan Sheng
Corporate Officer/Principal at Massachusetts Institute of Technology
Profile
Morgan Sheng is a Professor at the Massachusetts Institute of Technology.
He was previously an Independent Director at Prevail Therapeutics, Inc. from 2019 to 2021 and a Vice President-Neuroscience at Genentech, Inc. He holds a doctorate degree from Harvard University and the University of London, and an undergraduate degree from the University of Oxford.
Morgan Sheng active positions
| Companies | Position | Start |
|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Former positions of Morgan Sheng
| Companies | Position | End |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Director/Board Member | 2021-01-21 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Morgan Sheng
| University of Oxford | Undergraduate Degree |
| University of London | Doctorate Degree |
| Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Morgan Sheng
